![Alex Rothwell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alex Rothwell
Financieel Directeur/CFO bij
EUPRAXIA PHARMACEUTICALS INC.
Vermogen: 7 M $ op 31-08-2026
Profiel
Alex Rothwell is Chief Financial Officer at Eupraxia Pharmaceuticals, Inc. since 2025.
Former roles include Independent Director at Alset AI Ventures, Inc. from 2017 to 2018, Senior Managing Partner at Orion Securities, Inc., and Head of Canadian Equities at Macquarie Capital Markets Canada Ltd. Education includes an undergraduate degree from McGill University in 1991 and an MBA from Richard Ivey School of Business in 1995.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-06-2026 | 1.104.000 ( 1,69% ) | 7 M $ | 31-08-2026 |
Actieve functies van Alex Rothwell
| Bedrijven | Functie | Begin |
|---|---|---|
| EUPRAXIA PHARMACEUTICALS INC. | Financieel Directeur/CFO | 18-02-2025 |
Eerdere bekende functies van Alex Rothwell
| Bedrijven | Functie | Einde |
|---|---|---|
| ALSET AI VENTURES INC. | Directeur/Bestuurslid | 10-12-2018 |
Orion Securities, Inc.
 Orion Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Macquarie Capital Markets Canada Ltd.
 Macquarie Capital Markets Canada Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Opleiding van Alex Rothwell
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
85
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Alset AI Ventures, Inc.
 Alset AI Ventures, Inc. Information Technology ServicesTechnology Services Provides investment services | Technology Services |
Eupraxia Pharmaceuticals, Inc.
 Eupraxia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on the development of delivered, extended-release alternatives to currently approved drugs | Health Technology |
Orion Securities, Inc.
Orion Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Macquarie Capital Markets Canada Ltd.
Macquarie Capital Markets Canada Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Richard Ivey School of Business
 Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
